51 results match your criteria: "Center for Translational Medicine and Immune Diagnostics Laboratory[Affiliation]"

Combined Administration of Metformin and Propionate Reduces the Degree of Oxidative/Nitrosative Damage of Hypothalamic Neurons in Rat Model of Type 2 Diabetes Mellitus.

Mol Neurobiol

October 2024

Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr University Bochum, Hölkeskampring 40, 44625, Herne, Germany.

Many complications associated with type 2 diabetes mellitus (T2DM) are closely linked with the generation of reactive species or free radicals leading to oxidative/nitrosative stress. The aim of this study was to investigate the effect of combined administration of metformin with propionate on the degree of oxidative/nitrosative damage in the brain of rats with an experimental model of T2DM. Male Wistar rats were divided into control (healthy rats); rats with T2DM and no further therapy; rats with T2DM that received: metformin, propionate, propionate + metformin.

View Article and Find Full Text PDF

Effects of switching from twice-daily tacrolimus to once-daily extended-release meltdose tacrolimus on cellular immune response.

Front Transplant

September 2024

Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Herne, Germany.

Article Synopsis
  • LCP-Tacro (LCPT) is a new once-daily formulation of tacrolimus for kidney transplant patients that allows for a 30% lower dosage while maintaining similar efficacy and safety compared to the traditional immediate-release tacrolimus (IR-Tac).
  • In a study involving 16 kidney transplant patients, researchers examined changes in T-cells and B-cells before and after switching from IR-Tac to LCPT, using detailed flow cytometry techniques.
  • The results showed no significant changes overall in immune cell populations post-conversion, but there was a notable transient increase in regulatory T cells and B cell expansion at 4 weeks that reverted thereafter, indicating some adaptive immune changes with the switch.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effects of propionic acid on inflammation and T-cell composition in kidney transplant patients compared to dialysis patients.
  • A total of 26 participants (10 dialysis and 16 transplant patients) received propionic acid supplementation for 30 days while their immune systems were analyzed before, after, and during follow-ups.
  • Results showed that propionic acid enhanced Treg expansion in dialysis patients but had no significant effect on Treg levels in transplant patients, likely due to the immunosuppressive therapy they were undergoing.
View Article and Find Full Text PDF

Osteosarcopenia, the concurrent presence of sarcopenia and osteopenia/osteoporosis, poses a significant health risk to older adults, yet its impact on clinical outcomes is not fully understood. The aim of this prospective, longitudinal multicentre study was to examine the impact of osteosarcopenia on 3-year mortality and unplanned hospitalizations among 572 older hospitalized patients (mean age 75.1 ± 10.

View Article and Find Full Text PDF

Increased SARS-CoV-2 reactive low avidity T cells producing inflammatory cytokines in pediatric post-acute COVID-19 sequelae (PASC).

Pediatr Allergy Immunol

December 2023

Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Bochum, Germany.

Background: A proportion of the convalescent SARS-CoV-2 pediatric population presents nonspecific symptoms, mental health problems, and a reduction in quality of life similar to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID-19 symptomatic. However, data regarding its clinical manifestation and immune mechanisms are currently scarce.

Methods: In this study, we perform a comprehensive clinical and immunological profiling of 17 convalescent COVID-19 children with post-acute COVID-19 sequelae (PASC) manifestation and 13 convalescent children without PASC manifestation.

View Article and Find Full Text PDF

9-Month observational Dia-Vacc study of vaccine type influence on SARS-CoV-2 immunity in dialysis and kidney transplant patients.

Vaccine

January 2024

Medizinische Klinik und Poliklinik III, Universitätsklinikum, Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; KfH-Nierenzentrum Dresden, Dresden, Germany. Electronic address:

Background: SARS-CoV-2mRNA vaccination related seroconversion rates are reduced in dialysis and kidney transplant patients.

Methods: We evaluated nine months follow up data in our observational Dia-Vacc study exploring specific cellular (interferon-γ release assay) or/and humoral immune responses after 2x SARS-CoV-2mRNA vaccination in 880 participants including healthy medical personnel (125-MP), dialysis patients (595-DP), kidney transplant recipients (111-KTR), and apheresis patients (49-AP) with positive seroconversion (de novo IgA or IgG antibody positivity by ELISA) after eight weeks.

Findings: Nine months after first vaccination, receptor binding domain (RBD) antibodies were still positive in 90 % of MP, 86 % of AP, but only 55 %/48 % of DP/KTR, respectively.

View Article and Find Full Text PDF

Cross-reactive cellular and humoral immunity can substantially contribute to antiviral defense against SARS-CoV-2 variants of concern (VOC). While the adult SARS-CoV-2 cellular and humoral immunity and its cross-recognition potential against VOC is broadly analyzed, similar data regarding the pediatric population are missing. In this study, we perform an analysis of the humoral and cellular SARS-CoV-2 response immune of 32 convalescent COVID-19 children (children), 27 convalescent vaccinated adults(C + V+) and 7 unvaccinated convalescent adults (C + V-).

View Article and Find Full Text PDF

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a devastating disease affecting millions of people worldwide. Due to the 2019 pandemic of coronavirus disease (COVID-19), we are facing a significant increase of ME/CFS prevalence. On May 11th to 12th, 2023, the second international ME/CFS conference of the Charité Fatigue Center was held in Berlin, Germany, focusing on pathomechanisms, diagnosis, and treatment.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the adaptive immune response in patients with post-acute sequelae of COVID-19 (PASC), focusing on the role of SARS-CoV-2 specific immunity.
  • It compares immune responses, particularly CD4+ and CD8+ T cell responses, between PASC patients and healthy COVID-19 convalescents, finding that PASC patients exhibit a stronger but low avidity CD8+ T cell response.
  • The findings suggest that an inflammatory response from activated low avidity pro-inflammatory CD8+ T cells may contribute to tissue damage and symptoms seen in PASC patients, indicating the need for more research to clarify the underlying mechanisms.
View Article and Find Full Text PDF

Polyneuropathies (PNP) are the most common type of disorder of the peripheral nervous system in adults. However, information on microRNA expression in PNP is lacking. Following microRNA sequencing, we compared the expression of microRNAs in the serum of patients experiencing chronic painful PNP with healthy age-matched controls.

View Article and Find Full Text PDF

Vaccination of SARS-CoV-2 with BNT162b2 or mRNA-1273 both have a low incidence of induction of myocarditis. Here we report on utilizing adaptive immune receptor repertoire sequencing (AIRR-Seq) as a way to assess the specificity of tissue infiltrating immune cells.

View Article and Find Full Text PDF

The critical balance between intended and adverse effects in allogeneic hematopoietic stem cell transplantation (alloHSCT) depends on the fate of individual donor T-cells. To this end, we tracked αβT-cell clonotypes during stem cell mobilization treatment with granulocyte-colony stimulating factor (G-CSF) in healthy donors and for six months during immune reconstitution after transfer to transplant recipients. More than 250 αβT-cell clonotypes were tracked from donor to recipient.

View Article and Find Full Text PDF

Immunogenicity of Bivalent Omicron BA.4/5-Adapted Vaccine in Hemodialysis Patients.

Kidney Int Rep

April 2023

Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Hölkeskampring, Herne, Germany.

View Article and Find Full Text PDF

BACKGROUNDThe fungus Aspergillus fumigatus causes a variety of clinical phenotypes in patients with cystic fibrosis (pwCF). Th cells orchestrate immune responses against fungi, but the types of A. fumigatus-specific Th cells in pwCF and their contribution to protective immunity or inflammation remain poorly characterized.

View Article and Find Full Text PDF
Article Synopsis
  • Scientists studied how different COVID-19 vaccines work against new virus variants, especially the Omicron strain.
  • They found that people who got the same type of vaccine multiple times had strong immunity, but there was a bit less protection against Omicron compared to earlier versions of the virus.
  • Both types of vaccination (same or different vaccines) created a strong immune response, which can help decide future health guidelines.
View Article and Find Full Text PDF

Accurate measurement of cortical bone parameters may improve fracture risk assessment and help clinicians on the best treatment strategy. Patients at risk of fracture are currently detected using the current X-Ray gold standard DXA (Dual XRay Absorptiometry). Different alternatives, such as 3D X-Rays, Magnetic Resonance Imaging or Quantitative Ultrasound (QUS) devices, have been proposed, the latter having advantages of being portable and sensitive to mechanical and geometrical properties.

View Article and Find Full Text PDF

Lack of predictive capacity of pre-transplant anti-BK virus antibodies for post-transplant reactivation.

J Nephrol

May 2023

Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, Ruhr-University Bochum, University Hospital of the Ruhr-University Bochum, Herne, North Rhine-Westphalia, Germany.

View Article and Find Full Text PDF

Background: Hypothalamic dysregulation may cause abnormal glucose metabolism and type 2 diabetes mellitus (T2DM). The balance between autophagy and apoptosis is important for maintaining cellular/tissue homeostasis and may be disrupted in T2DM.

Objectives: Since propionic acid (PA) exerts neuroprotective effects, the aim was to investigate its effects on apoptosis/autophagy switch in the ventromedial hypothalamus (VMH) of T2DM rats.

View Article and Find Full Text PDF

Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination.

Front Immunol

November 2022

Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Bochum, Germany.

Emerging variants of concern (VOC) raise obstacles in shaping vaccination strategies and ending the pandemic. Vaccinated SARS-CoV-2 convalescence shapes the current immune dynamics. We analyzed the SARS-CoV-2 VOC-specific cellular and humoral response of 57 adults: 42 convalescent mRNA vaccinated patients (C+V+), 8 uninfected mRNA vaccinated (C-V+) and 7 unvaccinated convalescent individuals (C+V-).

View Article and Find Full Text PDF

SARS-CoV-2 vaccination improves HBV seroconversion rate through heterological immunity.

Kidney Int

January 2023

Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Herne, Germany; Berlin Institute of Health, Berlin-Brandenburg Center for Regenerative Therapies, and Institute of Medical Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany. Electronic address:

View Article and Find Full Text PDF
Article Synopsis
  • - The study examined how various immunosuppressive therapies affect immune responses in patients with autoimmune inflammatory rheumatic diseases (AIRDs) after receiving two doses of an mRNA-based COVID-19 vaccine.
  • - Among 92 patients, the first vaccination showed only 37.8% developed neutralizing antibodies, while 94.5% achieved this after the second dose; those on IL-17 inhibitors had the highest antibody levels.
  • - Despite differences in treatments, T-cell immunity was similar across therapy types, indicating a generally positive response to vaccination, particularly following the second dose, especially for patients on IL-17 inhibitors.
View Article and Find Full Text PDF

In vitro and in vivo evidence that the switch from calcineurin to mTOR inhibitors may be a strategy for immunosuppression in Epstein-Barr virus-associated post-transplant lymphoproliferative disorder.

Kidney Int

December 2022

BIH Center for Regenerative Therapies (BCRT), Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany; Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, Ruhr-University Bochum, Herne, Germany. Electronic address:

Article Synopsis
  • Post-transplant lymphoproliferative disorder is a serious condition that arises in transplant patients due to weak T cell responses against the Epstein-Barr virus (EBV), often exacerbated by immunosuppressive medication.
  • The study aimed to analyze T cells and lymphoblastoid cell lines from kidney transplant recipients to better understand their responses to various immunosuppressants, revealing differing impacts on T cell function and proliferation.
  • Findings suggest that adjusting immunosuppression—particularly using mTOR inhibitors and reducing certain drugs like calcineurin inhibitors—could enhance antiviral immunity while still preventing organ rejection in patients at risk for EBV-related complications.
View Article and Find Full Text PDF

Infection is the second leading cause of death in patients with chronic kidney disease (CKD). Adequate humoral (antibody) and cellular (T cell-driven) immunity are required to minimize pathogen entry and promote pathogen clearance to enable infection control. Vaccination can generate cellular and humoral immunity against specific pathogens and is used to prevent many life-threatening infectious diseases.

View Article and Find Full Text PDF